What is the maximum dose of gliclazide (sulfonylurea) 60mg tablet per day?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Dose of Gliclazide 60mg Tablet

The maximum daily dose of gliclazide 60mg modified-release (MR) tablets is 120mg per day, which equals two tablets daily. 1

Dosing Guidelines for Gliclazide MR 60mg

  • Initial dosing typically starts with one 60mg tablet daily, which can be increased based on glycemic response 2, 1
  • For patients requiring additional glycemic control, dosage can be increased to 1½ tablets (90mg) as an intermediate step before reaching the maximum dose 1
  • The maximum recommended dose is 120mg (two 60mg tablets) daily 1, 3
  • Gliclazide MR should be administered as a once-daily dose, preferably before the first meal of the day 2, 4

Efficacy and Dose-Response Relationship

  • Clinical studies show that increasing the dose of gliclazide MR correlates with improved glycemic control 1:
    • One tablet (60mg): Mean fasting plasma glucose reduction of 48.7 mg/dl 1
    • One and a half tablets (90mg): Mean fasting plasma glucose reduction of 71.3 mg/dl 1
    • Two tablets (120mg): Mean fasting plasma glucose reduction of 86.3 mg/dl 1
  • At the maximum dose of 120mg daily, approximately 77.5% of patients achieved target glycemic control 1

Special Considerations for Renal Impairment

  • Unlike some sulfonylureas that require significant dose adjustments in renal impairment, gliclazide is primarily metabolized by the liver 2
  • For patients with GFR <30 ml/min/1.73 m², gliclazide may need dose reduction but can still be used with caution 2
  • This contrasts with glyburide/glibenclamide which should be avoided in renal impairment 2

Safety Profile

  • Hypoglycemia risk with gliclazide MR is relatively low compared to other sulfonylureas, with studies showing hypoglycemia rates of approximately 0.7% 1
  • Comparative studies have shown fewer hypoglycemic episodes with gliclazide MR compared to glimepiride (3.7% vs 8.9% of patients) 5
  • No severe hypoglycemic episodes requiring third-party assistance were observed in clinical trials with gliclazide MR 4

Practical Dosing Recommendations

  • For patients with type 2 diabetes inadequately controlled on diet and exercise: Start with one 60mg tablet daily 4
  • For patients switching from another oral antidiabetic: Start with one 60mg tablet and adjust based on glycemic response 2
  • During Ramadan: For patients on once-daily gliclazide MR, the dose should be given before the sunset meal (Iftar) 2
  • For elderly patients: Start with the standard dose, as studies show similar efficacy and safety profiles to the general population 4

Common Pitfalls to Avoid

  • Avoid exceeding the maximum daily dose of 120mg as this does not provide additional benefit but may increase the risk of adverse effects 1, 3
  • Do not split or crush gliclazide MR tablets as this will affect the modified-release properties (unless they are specifically scored, breakable formulations) 1
  • Be cautious when combining with insulin, as this combination may increase the risk of hypoglycemia 2
  • Monitor patients closely during acute illness, as sulfonylureas may need to be temporarily suspended during intercurrent illness 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.